Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 2 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Application WO-2018134782-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.